Mono Pharmacare Balance Sheet Health
Financial Health criteria checks 2/6
Mono Pharmacare has a total shareholder equity of ₹281.3M and total debt of ₹414.4M, which brings its debt-to-equity ratio to 147.3%. Its total assets and total liabilities are ₹811.1M and ₹529.8M respectively. Mono Pharmacare's EBIT is ₹63.1M making its interest coverage ratio 2. It has cash and short-term investments of ₹3.6M.
Key information
147.3%
Debt to equity ratio
₹414.40m
Debt
| Interest coverage ratio | 2x |
| Cash | ₹3.63m |
| Equity | ₹281.28m |
| Total liabilities | ₹529.84m |
| Total assets | ₹811.13m |
Financial Position Analysis
Short Term Liabilities: MONOPHARMA's short term assets (₹801.6M) exceed its short term liabilities (₹358.2M).
Long Term Liabilities: MONOPHARMA's short term assets (₹801.6M) exceed its long term liabilities (₹171.7M).
Debt to Equity History and Analysis
Debt Level: MONOPHARMA's net debt to equity ratio (146%) is considered high.
Reducing Debt: Insufficient data to determine if MONOPHARMA's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if MONOPHARMA's debt is well covered by operating cash flow.
Interest Coverage: MONOPHARMA's interest payments on its debt are not well covered by EBIT (2x coverage).